Dr. Arielle Selya is a behavioral science consultant specializing in tobacco harm reduction. Through her primary role as Senior Scientist at PinneyAssociates, Inc., she supports Juul Labs, Inc. in their scientific and regulatory efforts through behavioral study protocols, statistical methodology, and scientific publishing strategy and execution. Dr. Selya is also a consultant to the Center of Excellence for the Acceleration of Harm Reduction (CoEHAR) on e-cigarette use behavioral research and critical analysis of scientific literature. She received her PhD in Neuroscience at Rutgers University and, prior to becoming a consultant, spent a decade in academia studying adolescent substance use and addiction. In addition to being a prolific contributor to the scientific literature, with over 70 scientific publications to her name, Dr. Selya is also actively engaged in both post-publication critiques of published research and in communicating scientific findings to broader audiences (see her collection of tweetorials here).